Novonesis (Novozymes) B
(OCSE:NSIS B)
kr
412.9
-5.9 (-1.41%)
Market Cap: 191.73 Bil
Enterprise Value: 204.61 Bil
PE Ratio: 37.86
PB Ratio: 2.34
GF Score: 94/100 
Half Year 2024 Novozymes A/S Earnings Call TranscriptAug 28, 2024kr462.1 (+1.56%)Earnings- Novozymes A/S 2024 Outlook and 2023 Pro Forma Financials Call TranscriptMar 21, 2024
- Novozymes A/S Extraordinary Shareholders Meeting TranscriptMar 04, 2024
- Q4 2023 Novozymes A/S Earnings Call TranscriptFeb 01, 2024kr371.6 (+4.88%)Earnings
- Q3 2023 Novozymes A/S Earnings Call TranscriptOct 26, 2023kr299.9 (+7.96%)Earnings
- Q2 2023 Novozymes A/S Earnings Call TranscriptAug 09, 2023kr327.7Earnings
- Q1 2023 Novozymes A/S Earnings Call TranscriptApr 26, 2023kr355.2 (-3.53%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 02, 2023
- Q4 2022 Novozymes A/S Earnings Call TranscriptJan 26, 2023kr348.3 (-0.68%)Earnings
- Novozymes A/S and Chr Hansen Holding A/S to Discuss Agreement to Combine Through a Statutory Merger Call TranscriptDec 12, 2022
- Q3 2022 Novozymes A/S Earnings Call TranscriptNov 03, 2022kr395 (+1.28%)Earnings
- Q2 2022 Novozymes A/S Earnings Call TranscriptAug 11, 2022kr452.5 (+3.00%)Earnings
- Novozymes A/S Spotlight on Human Health Presentation TranscriptJun 17, 2022
- Q1 2022 Novozymes A/S Earnings Call TranscriptApr 27, 2022kr483.2 (+2.83%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 16, 2022
- Q4 2021 Novozymes A/S Earnings Call TranscriptFeb 01, 2022kr441 (-2.63%)Earnings
- Q3 2021 Novozymes A/S Earnings Call TranscriptOct 27, 2021kr472 (+0.62%)Earnings
- Novozymes A/S Capital Markets Day (Virtual) TranscriptSep 28, 2021
- Q2 2021 Novozymes A/S Earnings and to Discuss Investment Into Advanced Protein Solutions Call TranscriptAug 12, 2021
- Q1 2021 Novozymes A/S Earnings Call TranscriptApr 27, 2021kr444.7 (+5.58%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 11, 2021
- Q4 2020 Novozymes A/S Earnings Call TranscriptFeb 02, 2021kr373.4 (-0.69%)Earnings
- Q3 2020 Novozymes A/S Earnings Call TranscriptOct 21, 2020kr392.5 (-5.38%)Earnings
- Q2 2020 Novozymes A/S Earnings Call TranscriptAug 12, 2020kr368.9 (-3.76%)Earnings
- Q2 2020 Novozymes A/S Trading Update Call TranscriptJul 08, 2020
- Q1 2020 Novozymes A/S Earnings Call TranscriptApr 29, 2020kr326.2 (+2.35%)Earnings
- Q1 2020 Novozymes A/S Organic Sales Call TranscriptApr 07, 2020
- Novozymes A/S Annual Shareholders Meeting TranscriptFeb 26, 2020
- Q4 2019 Novozymes A/S Earnings Call TranscriptJan 23, 2020kr351.4 (+6.65%)Earnings
- Q3 2019 Novozymes A/S Earnings Call TranscriptOct 23, 2019kr304.3 (+4.93%)Earnings
- Novozymes A/S to Discuss the Adjusted FY 2019 Outlook Call TranscriptOct 10, 2019
- Q2 2019 Novozymes A/S Earnings Call TranscriptAug 08, 2019kr288.8 (-4.31%)Earnings
- Novozymes A/S Capital Markets Day 2019 TranscriptJun 17, 2019
- Q1 2019 Novozymes A/S Earnings Call TranscriptApr 24, 2019kr309 (-2.49%)Earnings
- Novozymes A/S to Discuss the Continuation of Partnership with Bayer AG and with Two New Partners, Univar Solutions and UPL Ltd Call TranscriptApr 05, 2019
- Novozymes A/S Annual Shareholders Meeting TranscriptFeb 27, 2019
Novozymes A/S Spotlight on Human Health Presentation Transcript
Jun 17, 2022 / 12:00PM GMT
Release Date Price:
kr399.3
(+0.03%)
Operator
Presentation
Jun 17, 2022 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Ulrich Irgens
=====================
Conference Call Participants
=====================
* Alexander Jones
BofA Securities, Research Division - Analyst
* André Thormann
Danske Bank A/S, Research Division - Analyst
* Lars Topholm
Carnegie Investment Bank AB, Research Division - Co-Head of Research of Denmark & Financial Analyst
=====================
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers